跳至主要内容
临床试验/NCT05026658
NCT05026658已完成不适用

A Prospective, Randomized, Controlled Clinical Study to Evaluate the Agreement and Reproducibility of Visibly Digital Acuity Product

Visibly6 个研究点 分布在 1 个国家目标入组 358 人开始时间: 2021年7月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Visibly
入组人数
358
试验地点
6
主要终点
Reproducibility

研究概览

简要总结

Visual acuity is the relative ability of the eye to resolve detail that is usually expressed as the reciprocal of the minimum angular separation in minutes of two lines just resolvable as separate and that forms in the average human eye an angle of one minute.

Visibly Inc. has developed a method for determining a patient's visual acuity electronically via a web-based software system that can be self-administered wherever convenient. This method provides an efficient alternative for people to have immediate access to visual acuity measurements.

详细描述

The Visibly Digital Acuity Product (VDAP) is a web-based, self-guided software application intended for use by adults, ages 22 to 40, at home, to evaluate visual acuity with or without correction. The standalone software application allows the user to interface with the software via a web browser on two internet-enabled devices:

  • A computer screen (the Display) which displays optotypes
  • A touchscreen mobile device (the Remote) which operates as a remote control and interface for the user to respond to prompts related to the optotypes appearing on the Display while standing 10 feet away

The software allows users to view and respond to displayed optotypes and uses the responses to categorize a user's visual acuity into one of two buckets:

  • 20/25 or better
  • Worse than 20/25

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
22 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Be between 22 and 40 years (inclusive) of age at the time of consent
  • Be able and willing to provide written informed consent, attend all scheduled visits and comply with all study procedures

排除标准

  • Have any of the following conditions (based on subject report):
  • Advanced eye disease in either eye;
  • Poor vision as a result of refractive surgery in either eye;
  • Unable to walk;
  • Unable to hear or follow audio instructions.

结局指标

主要结局

Reproducibility

时间窗: Up to 3 hours

The proportion of study eyes which receive the same VA classification (20/25 or Better vs. Worse than 20/25) for the two VDAP tests

Effectiveness

时间窗: Up to 3 hours

The proportion of study eyes with VDAP VA of 20/25 or better 20/25 or better \[Positive Predictive Value (PPV)\]

次要结局

  • Reproducibility(Up to 3 hours)
  • Effectiveness(Up to 3 hours)

研究者

发起方
Visibly
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验